Loading market dashboard
HLS Therapeutics Inc.
HLS.TOHealthcareTSXCA
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
HLS Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $94.46M | $92.77M - $97.29M | $29.17M | $0.37 | 1 |
| Dec 2029 | $84.16M | $82.65M - $86.67M | $25.98M | $0.24 | 1 |
| Dec 2028 | $77.25M | $75.87M - $79.56M | $23.85M | $0.07 | 2 |
| Dec 2027 | $64.36M | $62.68M - $67.34M | $19.87M | -$0.03 | 3 |
| Dec 2026 | $58.09M | $57.58M - $58.76M | $17.94M | -$0.27 | 4 |
| Dec 2025 | $55.11M | $54.44M - $55.74M | $17.01M | -$0.39 | 3 |
| Dec 2024 | $56.76M | $56.50M - $57.00M | $17.52M | -$0.61 | 5 |
| Dec 2023 | $43.07M | $42.31M - $44.36M | $13.30M | -$0.55 | 2 |
| Dec 2022 | $63.51M | $61.99M - $65.14M | $20.81M | -$0.642 | 2 |
| Dec 2021 | $60.14M | $58.70M - $61.69M | $19.70M | -$0.374 | 3 |
| Dec 2020 | $55.26M | $53.93M - $56.68M | $18.10M | -$0.359 | 3 |
| Dec 2019 | $52.59M | $51.33M - $53.95M | $17.23M | -$0.334 | 2 |